Archives: Month: June 2026

“Baby TAM” After DCIS: What New Research Says About Menopausal Status and Your Risk

If you’ve been treated for ductal carcinoma in situ (DCIS) and had a conversation with your doctor about tamoxifen, you may have heard about a lower-dose option sometimes called “baby TAM.” New research presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2026 — and simultaneously published in the Journal of Clinical Oncology — sheds important light on how well this low-dose approach works, and why your menopausal status may matter more than previously understood.

Read more